Ibio Inc (IBIO)
$1.48
0.01 (0.67%)
IBIO Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're really starting to get into earnings season with many of the biggest pre-market stock movers today connected to earnings news.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
319.69M
PE Ratio
49.33
EPS
0.03
Volume (Avg. Vol.)
3.84M
Day's Range
1.44 - 1.53
52-Week Range
1.01 - 7.45
Dividend & Yield
N/A (N/A)
IBIO Stock Predictions, Articles, and Ibio Inc News
The Top Reason to Consider iBio Stock in the Long Term
Don't bet on iBio for its coronavirus vaccine candidate. It's the company’s FastPharming System that could move IBIO stock in the long term.
iBio Stock Is Not Likely To Move Higher Given Its Huge Dilution
IBIO stock is not likely to move higher given its huge dilution. I think it is not worth more than 48 cents per share.
Hold iBio Shares as Q2 Highlights Strong Product Catalog
With iBio making key executive-level appointments and recording excellent fiscal stats, IBIO stock's value proposition is hard to ignore.
IBIO Stock: 5 Things for Investors to Know About iBio Today as Shares Zoom Higher
Ibio (IBIO) stock is on the rise Thursday despite a lack of news coming out today that would result in the movement today.
IBIO Stock Alert: Analyst Call Sends Shares of Pharma iBio Soaring
Shares of IBIO stock are taking off on Friday after an analyst from Cantor Fitzgerald initiated an Overweight rating and $3 price target.
Be Wary as iBio Seeks a Place in the Vaccine Game
IBIO stock remains volatile as the company continues its focus on a breakthrough product to combat the coronavirus pandemic.
A Lack of Progress Keeps IBIO Shares As a Sell
Investors bought the Covid-19 hype in IBIO stock. With little progress made, however, reality is setting in, which means the fade should continue.
Firming Financials Point to an Underappreciation of iBio Stock
The IBIO stock price is down, but that doesn't mean the company's in trouble. In fact, the data shows that iBio's fiscal health is improving.
Why iBio Remains Worth a Look In a Post-Pandemic Landscape
While its shot at pioneering a novel coronavirus vaccine has passed, iBio and its IBIO stock could benefit from other medical breakthroughs.
Biotech Innovator IBIO Is Down, but Not Out for the Long Term
Biotech innovator IBIO stock has been tossed around based on iBio’s COVID-19 vaccine progress, but its FastPharma tech is the long-term play.
iBio News: Why IBIO Stock Is Soaring 16% Today
Ibio (IBIO) is seeing shares of IBIO stock soar higher on Wednesday following news of a contract for the biotech company.
The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered
iBio has a long-standing relationship with the United States defense industry. But that hasn't enough to give IBIO stock a leg up in the Covid-19 race.
